- Investment of under €1.5 million will be made in H2 2021 to transfer key equipment to Pomacle.
- Production will enable conversion of over 10 million longwear make-up units per year by H1 2022.
- First full-scale test of the 180 m3 fermenter was successfully completed at Pomacle.
- By 2023, production will scale to support over 200 million make-up units with natural ingredients.
Production Scale-Up
Global Bioenergies is advancing its isobutene bio-production process by implementing a two-stage method. The first stage, involving the production of isobutene precursor, can now utilize existing fermentation capacities, enhancing flexibility and economic efficiency. The second stage, converting the precursor into isobutene, requires a specific explosion-proof reactor and is highly productive.
Successful Testing
A full-scale test of the first stage was successfully completed at Pomacle using a 180 m3 industrial fermenter operated by ARD, a leading developer of fermentation processes. The second stage was also successfully tested at pilot scale, marking a significant milestone in the production process.
Equipment Transfer
Following these successes, Global Bioenergies plans to move key equipment from its Leuna plant to the ARD facility at Pomacle. This includes the 5 m3 fermenter, which will be used for the second stage of the process. The transfer and final technical adjustments are scheduled for the second half of 2021, with an investment of under €1.5 million.
Future Production Goals
By the first half of 2022, the company aims to produce over 10 million longwear make-up units per year using this optimized process. By 2023, production is expected to scale up to support over 200 million make-up units with natural ingredients, targeting both the cosmetics market and potential related markets in skincare, haircare, and other non-cosmetic sectors.
